Back to search

Controversies in the Use of Inhaled Nitric Oxide Therapy in the Newborn

Data up to Jan 2025

Published1998
Citations20
References60

Total Citations Per Year

Abstract

References (60)

Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome

1993 • 1,811 citations

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

1992 • 865 citations

Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure

1997 • 837 citations

Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn

1997 • 787 citations

Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn

1992 • 731 citations

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

1997 • 567 citations

Inhaled Nitric Oxide and Hypoxic Respiratory Failure in Infants With Congenital Diaphragmatic Hernia

1997 • 429 citations

Time‐course and dose‐response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome

1993 • 396 citations

Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide

1993 • 331 citations

Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response

1994 • 267 citations

Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation

1994 • 257 citations

Surfactant Treatment of Full-Term Newborns With Respiratory Failure

1991 • 253 citations

Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn

1995 • 226 citations

Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons

1989 • 224 citations

Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure

1994 • 223 citations

Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.

1993 • 204 citations

Effects of Inhaled Nitric Oxide on Pulmonary Edema and Lung Neutrophil Accumulation in Severe Experimental Hyaline Membrane Disease

1997 • 181 citations

Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung

1994 • 173 citations

Duration and characteristics of treatment of premature lambs with natural surfactant.

1981 • 155 citations

Inhaled nitric oxide for premature infants after prolonged rupture of the membranes

1995 • 146 citations

High-frequency ventilation

1994 • 140 citations

Inhaled Nitric Oxide in the Management of a Premature Newborn With Severe Respiratory Distress and Pulmonary Hypertension

1993 • 138 citations

Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation

1992 • 130 citations

Inhaled Nitric Oxide in Congenital Hypoplasia of the Lungs Due to Diaphragmatic Hernia or Oligohydramnios

1994 • 128 citations

Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation

1993 • 124 citations

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

1995 • 116 citations

High-Frequency Oscillatory Ventilation Versus Intermittent Mandatory Ventilation: Early Hemodynamic Effects in the Premature Baboon with Hyaline Membrane Disease

1991 • 108 citations

Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension

1995 • 104 citations

Inhaled Nitric Oxide Improves Gas Exchange and Lowers Pulmonary Vascular Resistance in Severe Experimental Hyaline Membrane Disease

1994 • 101 citations

Bronchoalveolar Inflammatory Pathophysiology of Bronchopulmonary Dysplasia

1995 • 93 citations

Nitric oxide inhalation in infants with respiratory distress syndrome

1997 • 91 citations

Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus

1995 • 88 citations

Effect of Inhaled Nitric Oxide during Group B Streptococcal Sepsis in Piglets

1993 • 87 citations

Nitric oxide is an antiadhesive molecule for leukocytes.

1995 • 86 citations

Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension

1993 • 80 citations

Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation

1994 • 79 citations

Neoenatal Pulmonary Hypertension: Pathophysiology Classification and Etiology

1984 • 79 citations

The Clinical Profile of the Newborn with Persistent Pulmonary Hypertension

1977 • 70 citations

Nitric Oxide Reverses Acute Hypoxic Pulmonary Hypertension in the Newborn Piglet

1994 • 61 citations

Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation

1990 • 57 citations

The Effect of Inhaled Nitric Oxide on the Pulmonary Circulation of the Neonatal Pig

1994 • 54 citations

Inhalational Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1993 • 52 citations

Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: The Physiology Matters

1995 • 48 citations

High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn

1992 • 48 citations

The Effects of Nitric Oxide Inhalation on the Pulmonary Circulation of Preterm Lambs

1995 • 47 citations

Inhaled Nitric Oxide Treatment for Stabilization and Emergency Medical Transport of Critically Ill Newborns and Infants

1995 • 46 citations

Non-specificity of surfactant deficiency in neonatal respiratory disorders.

1984 • 45 citations

A DOUBLE MASKED, RANDOMIZED, PLACEBO CONTROLLED, DOSE-RESPONSE STUDY OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN). • 851

1997 • 43 citations

A comparison of ventilation strategies for the use of high‐frequency oscillatory ventilation in the treatment of hyaline membrane disease

1989 • 43 citations

Efficacy of Inhalational Nitric Oxide Therapy in the Clinical Management of Persistent Pulmonary Hypertension of the Newborn

1994 • 36 citations

Cerebral hemodynamics and distribution of left ventricular output during inhalation of nitric oxide

1995 • 29 citations

Evidence of surfactant deficiency in persistence of the fetal circulation

1980 • 23 citations

Single Versus Repetitive Doses of Natural Surfactant as Treatment of Respiratory Distress Syndrome in Premature Lambs

1985 • 23 citations

IMPROVED OXYGENATION IN A RANDOMIZED TRIAL OF INHALED NITRIC OXIDE FOR PPHN.• 1498

1996 • 17 citations

ELEVATION OF PULMONARY PDE5-SPECIFIC ACTIVITY IN AN EXPERIMENTAL FETAL OVINE PERINATAL PULMONARY HYPERTENSION MODEL. † 1990

1996 • 16 citations

SURVANTA® PRE-ECMO TRIAL: MULTICENTER EVALUATION OF SURVANTA® IN TREATMENT OF TERM INFANTS WITH SEVERE RESPIRATORY FAILURE. • 1341

1996 • 9 citations

HIGH FREQUENCY OSCILLATORY VENTILATION AUGMENTS THE RESPONSE TO INHALED NITRIC OXIDE IN SEVERE EXPERIMENTAL HYALINE MEMBRANE DISEASE. † 2001

1996 • 5 citations

HEMODYNAMIC EFFECTS OF DIPYRIDAMOLE AND INHALED NITRIC OXIDE IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION. † 228

1996 • 3 citations

Randomized, controlled trial of low dose inhalational nitric oxide in presistent pulmonary hypertension of the newborn (PPHN). • 848

1997 • 2 citations

DIPYRIDAMOLE, A cGMP PHOSPHODIESTERASE INHIBITOR, ATTENUATES REBOUND PULMONARY HYPERTENSION AFTER WITHDRAWAL OF INHALED NITRIC OXIDE IN POSTOPERATIVE CONGENITAL HEART DISEASE. • 163

1996 • 1 citations

Cited By (0)

Loading...